首页> 外文期刊>Anesthesiology >Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study.
【24h】

Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study.

机译:血浆蛋白质组学在肝移植后寻找早期细菌性败血症的诊断生物标志物:一项初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: While outcome continuously improves after liver transplantation, sepsis remains the leading cause of early postoperative mortality. Diagnosis of infections remains particularly difficult in these patients. This study used plasma profiling coupling Proteinchip array with surface-enhanced laser desorption ionization time-of-fly mass spectrometry to search for biomarkers of postoperative sepsis in patients who underwent liver transplantation. METHODS: Diagnosis of sepsis at day 5 relied on widely accepted clinical signs and positive culture of microbiologic samples. Profiles of day 5 plasma were obtained from SELDI-TOF CM10 chip (BioRad, Marnes-la-Coquette, France) analysis. Mean peak intensity of proteins was compared between septic and nonseptic plasma by U test followed by analysis of the area under the receiver-operating characteristic for the significant peaks. Diagnostic performance of significant proteins was established in a derivation set and in a validation set. RESULTS: In the derivation set of 31 patients with and 30 without infection, 23 plasma protein peaks were differentially expressed between patients with and without sepsis. Combination of five peaks allowed sepsis diagnosis with a positive likelihood ratio of 12.5 and a C-statistics of 0.72, 95% CI 0.57-0.85. In the validation set of 31 patients with infection and 34 without infection, the five peaks were differentially expressed as well and allowed day 5 sepsis diagnosis with a positive likelihood ratio of 5.1 and C-statistics of 0.74 (0.58-0.85). CONCLUSION: A combination of five plasma protein peaks may provide material for useful diagnostic biomarkers of postoperative sepsis in patients undergoing liver transplantation. However, these proteins remain to be identified.
机译:背景:尽管肝移植后结局不断改善,但败血症仍然是术后早期死亡的主要原因。在这些患者中,感染的诊断仍然特别困难。这项研究使用血浆分析偶联Proteinchip阵列与表面增强的激光解吸电离飞行时间质谱技术来寻找接受肝移植的患者术后败血症的生物标志物。方法:败血症在第5天的诊断取决于广泛接受的临床体征和微生物标本的阳性培养。从SELDI-TOF CM10芯片(BioRad,Marnes-la-Coquette,法国)分析获得第5天血浆的概况。通过U检验比较化脓性血浆和非化脓性血浆中蛋白质的平均峰强度,然后分析接收器操作特征下显着峰的面积。在派生集和验证集中建立了重要蛋白质的诊断性能。结果:在31例有感染和30例没有感染的患者的派生组中,有和没有败血症的患者之间差异表达23个血浆蛋白峰。五个峰的组合允许败血症诊断,阳性似然比为12.5,C统计量为0.72,95%CI为0.57-0.85。在验证的31例感染患者和34例未感染患者的验证集中,五个峰也有差异表达,并允许在第5天进行败血症诊断,阳性似然比为5.1,C统计量为0.74(0.58-0.85)。结论:五个血浆蛋白峰的组合可为肝移植患者术后败血症的有用诊断生物标志物提供材料。但是,这些蛋白质仍有待鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号